Ads

 

Ads

 

Ads

 

Nasdaq or NYSE related Medicinal Chemicals and Botanical Products industry Top Companies List by Market Cap as of August 2026

Nasdaq or NYSE listed Medicinal Chemicals and Botanical Products industry Top Companies List by Market Cap as of August 2026. Nasdaq and NYSE related Medicinal Chemicals and Botanical Products industry Largest Companies List by Market Cap as of August 2026

  1. Philip Morris International

    World Rank (Aug-2026)
    59
    Market Cap (Aug-2026)
    296.744 Billion USD
    World Rank (Jan-05-2024)
    85
    Market Cap (Jan-05-2024)
    148.504 Billion USD
    World Rank (Jul-30-2023)
    75
    Market Cap (Jul-30-2023)
    155.000 Billion USD
    World Rank (Dec-25-2022)
    61
    Market Cap (Dec-25-2022)
    157.640 Billion USD
    World Rank (Jan-07-2022)
    87
    Market Cap (Jan-07-2022)
    154.34 Billion USD
    Annual Revenue in USD
    40,648 Million USD
    Annual Operating Income in USD
    14,892 Million USD
    Annual Net Income in USD
    11,348 Million USD
    Annual Results for Period Ending
    Dec-2025 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Philip Morris International is Cigarettes and Heated Tobacco Products manufacturing company with headquarters is in USA. Philip Morris International is a tobacco company. Six of the world's top international 15 brands, spanning more than 180 markets belongs to Philip Morris International Inc, including Marlboro, the world's number one. They operate and own 46 production facilities.

    Facts About Company

    As on 2022, Philip Morris International has 79,800 employees.

    Philip Morris International annual revenue generated for period ending Dec-2022 was 31,762 million USD.

    Philip Morris International annual net income generated for period ending Dec-2022 was 9,024 million USD.

    2021 Financial Highlights:

  2. British American Tobacco

    World Rank (Aug-2026)
    188
    Market Cap (Aug-2026)
    123.699 Billion USD
    World Rank (Jan-05-2024)
    243
    Market Cap (Jan-05-2024)
    67.042 Billion USD
    World Rank (Jul-30-2023)
    192
    Market Cap (Jul-30-2023)
    76.518 Billion USD
    World Rank (Dec-25-2022)
    147
    Market Cap (Dec-25-2022)
    90.776 Billion USD
    World Rank (Jan-07-2022)
    178
    Market Cap (Jan-07-2022)
    89.47 Billion USD
    Annual Revenue in USD
    35,522 Million USD
    Annual Operating Income in USD
    14,550 Million USD
    Annual Net Income in USD
    8,499 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    British American Tobacco is UK based Tobacco related products manufacturing company with more than 55,000 employees working for it as on 2021. Headquarters is in UK.

    The company products as sold in the US, including Vuse, Velo, Grizzly, Kodiak, and Camel Snus, are subject to FDA regulation and no reduced-risk claims will be made as to these products without agency clearance.

    BAT brands :

    • Vogue
    • Viceroy
    • Kool
    • Peter Stuyvesant
    • Craven A
    • State Express 555
    • Shuang Xi
    Facts About Company

    British American Tobacco annual revenue was 149,004 Million GBP and annual net income was 6,617 Million GBP for year ending Dec-2022.

    British American Tobacco annual revenue generated for period ending Dec-2021 was 25,684 million GBP.

    Split of Annual Revenue by business segment for period ending Dec-2021:

  3. Altria Group

    World Rank (Aug-2026)
    217
    Market Cap (Aug-2026)
    109.702 Billion USD
    World Rank (Jan-05-2024)
    207
    Market Cap (Jan-05-2024)
    73.434 Billion USD
    World Rank (Jul-30-2023)
    176
    Market Cap (Jul-30-2023)
    81.201 Billion USD
    World Rank (Dec-25-2022)
    157
    Market Cap (Dec-25-2022)
    82.870 Billion USD
    World Rank (Jan-07-2022)
    171
    Market Cap (Jan-07-2022)
    91.43 Billion USD
    Annual Revenue in USD
    20,139 Million USD
    Annual Operating Income in USD
    9,899 Million USD
    Annual Net Income in USD
    6,947 Million USD
    Annual Results for Period Ending
    Dec-2025 ending year
    Headquarters Country
    Stock Category
    Company Profile

    ​Altria Group is USA based Tobacco and Cigarette related Products Company. Altria Group holds diversified positions across tobacco, alcohol and cannabis. Headquarters is in USA.

    As on 2022, Altria Group has 6,300 employees.

    Facts About Company

    Altria Group annual revenue generated for period ending Dec-2022 was 20,688 million USD.

    Altria Group annual net income generated for period ending Dec-2022 was 5,764 million USD.

    As on 2022, ​Altria Group has over 6,300 employees.

    Altria Group annual revenue generated for period ending Dec-2021 was 21,111 million USD.

    ​Altria Group annual net income generated for period ending Dec-2021 was 2,464 million USD.

  4. Viatris Inc

    World Rank (Aug-2026)
    1,316
    Market Cap (Aug-2026)
    18.642 Billion USD
    World Rank (Jan-05-2024)
    1,267
    Market Cap (Jan-05-2024)
    13.856 Billion USD
    World Rank (Jul-30-2023)
    1,399
    Market Cap (Jul-30-2023)
    12.470 Billion USD
    World Rank (Dec-25-2022)
    1,190
    Market Cap (Dec-25-2022)
    13.352 Billion USD
    World Rank (Jan-07-2022)
    1,151
    Market Cap (Jan-07-2022)
    17.83 Billion USD
    Annual Revenue in USD
    14,250 Million USD
    Annual Operating Income in USD
    -2,663 Million USD
    Annual Net Income in USD
    -3,515 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Stock Category
    Company Profile

    VIATRIS INC is a Pharmaceutical company. The headquarters is in Pennsylvania, USA.

    VIATRIS INC better access to customers and patients in more than 165 countries and territories.

    VIATRIS INC total number of employees in 2022 was 37,000.

    VIATRIS INC annual revenue generated for period ending Dec-2022 was 16,262 million USD.

    VIATRIS INC annual net income generated for period ending Dec-2022 was 2,078 million USD.

  5. Kymera Therapeutics Inc.

    World Rank (Aug-2026)
    2,250
    Market Cap (Aug-2026)
    9.761 Billion USD
    World Rank (Jan-05-2024)
    6,735
    Market Cap (Jan-05-2024)
    1.510 Billion USD
    World Rank (Jul-30-2023)
    7,820
    Market Cap (Jul-30-2023)
    1.208 Billion USD
    World Rank (Dec-25-2022)
    6,679
    Market Cap (Dec-25-2022)
    1.453 Billion USD
    World Rank (Jan-07-2022)
    5,018
    Market Cap (Jan-07-2022)
    2.86 Billion USD
    Annual Revenue in USD
    39 Million USD
    Annual Operating Income in USD
    -349 Million USD
    Annual Net Income in USD
    -311 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Kymera is a Biopharmaceutical company. It is a developing novel protein degrader therapeutics to treat disease in powerful new ways which harness the body's natural protein degradation system to selectively degrade disease causing proteins with the goal of completely removing them from the body. The company annual revenue is 10.4 million USD and 67 employees as on 2019. The headquarters is in USA.
  6. Dyne Therapeutics Inc.

    World Rank (Aug-2026)
    3,727
    Market Cap (Aug-2026)
    4.799 Billion USD
    World Rank (Jan-05-2024)
    7,752
    Market Cap (Jan-05-2024)
    1.190 Billion USD
    World Rank (Jul-30-2023)
    10,793
    Market Cap (Jul-30-2023)
    0.686 Billion USD
    World Rank (Dec-25-2022)
    10,888
    Market Cap (Dec-25-2022)
    0.639 Billion USD
    World Rank (Jan-07-2022)
    12,704
    Market Cap (Jan-07-2022)
    0.56 Billion USD
    Annual Operating Income in USD
    -468 Million USD
    Annual Net Income in USD
    -446 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Dyne Therapeutics is a Biotechnology company building a Muscle Disease company focused on advancing innovative life transforming therapeutics for people living with genetically driven diseases. The headquarters is in USA.
    Facts About Company
    Dyne Therapeutics company annual revenue was 0 million USD and annual net loss was  -168 million USD as on Dec-2022.
  7. Immunome Inc.

    World Rank (Aug-2026)
    4,957
    Market Cap (Aug-2026)
    3.089 Billion USD
    World Rank (Jan-05-2024)
    12,539
    Market Cap (Jan-05-2024)
    0.505 Billion USD
    World Rank (Jul-30-2023)
    22,195
    Market Cap (Jul-30-2023)
    0.091 Billion USD
    World Rank (Dec-25-2022)
    26,459
    Market Cap (Dec-25-2022)
    0.038 Billion USD
    World Rank (Jan-07-2022)
    20,901
    Market Cap (Jan-07-2022)
    0.14 Billion USD
    Annual Revenue in USD
    7 Million USD
    Annual Operating Income in USD
    -224 Million USD
    Annual Net Income in USD
    -212 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
  8. Tarsus Pharmaceuticals Inc.

    World Rank (Aug-2026)
    5,005
    Market Cap (Aug-2026)
    3.037 Billion USD
    World Rank (Jan-05-2024)
    10,892
    Market Cap (Jan-05-2024)
    0.662 Billion USD
    World Rank (Jul-30-2023)
    11,446
    Market Cap (Jul-30-2023)
    0.614 Billion USD
    World Rank (Dec-25-2022)
    14,096
    Market Cap (Dec-25-2022)
    0.387 Billion USD
    World Rank (Jan-07-2022)
    13,834
    Market Cap (Jan-07-2022)
    0.47 Billion USD
    Annual Revenue in USD
    451 Million USD
    Annual Operating Income in USD
    -71 Million USD
    Annual Net Income in USD
    -66 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Tarsus Pharmaceuticals is a Late Clinical Stage Biopharmaceutical company focused on the development and commercialization of therapeutic candidates to address highly prevalent conditions with limited treatment options. It is having 20 employees as on 2019. The headquarters is in USA.
  9. RLX Technology Inc.

    World Rank (Aug-2026)
    5,036
    Market Cap (Aug-2026)
    3.005 Billion USD
    World Rank (Jan-05-2024)
    4,342
    Market Cap (Jan-05-2024)
    3.032 Billion USD
    World Rank (Jul-30-2023)
    4,715
    Market Cap (Jul-30-2023)
    2.670 Billion USD
    World Rank (Dec-25-2022)
    3,353
    Market Cap (Dec-25-2022)
    3.885 Billion USD
    World Rank (Jan-07-2022)
    2,925
    Market Cap (Jan-07-2022)
    5.77 Billion USD
    Annual Revenue in USD
    1,337 Million USD
    Annual Net Income in USD
    318 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Stock Category
    Company Profile

    e-Vapor products manufacturing company with headquarters is in China.

  10. Regencell Bioscience Holdings Ltd

    World Rank (Aug-2026)
    5,355
    Market Cap (Aug-2026)
    2.695 Billion USD
    World Rank (Jan-05-2024)
    19,846
    Market Cap (Jan-05-2024)
    0.137 Billion USD
    World Rank (Jul-30-2023)
    16,994
    Market Cap (Jul-30-2023)
    0.243 Billion USD
    World Rank (Dec-25-2022)
    14,236
    Market Cap (Dec-25-2022)
    0.380 Billion USD
    World Rank (Jan-07-2022)
    14,583
    Market Cap (Jan-07-2022)
    0.42 Billion USD
    Headquarters Country

Share

Ads